Der Schmerz
-
A guideline for the treatment and diagnostic procedures in fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. ⋯ Psychotherapeutic programs tailored to FMS subgroups should be developed and tested.
-
Practice Guideline
[Principles of treatment, coordination of medical care and patient education in fibromyalgia syndrome and chronic widespread pain].
A guideline for the treatment and diagnostic procedures for fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. ⋯ The long-term treatment should be based on principles of basic psychosomatic care and shared decision making on treatment options.
-
Practice Guideline
[Multicomponent therapy for treatment of fibromyalgia syndrome].
A guideline for the treatment of fibromyalgia syndrome (FMS) was developed in cooperation with 10 German medical and psychological associations and 2 patient self-help groups. ⋯ Future studies should consider medication, other co-therapies and comorbidities. MT programs tailored to FMS subgroups should be tested.
-
Practice Guideline
[Alternative and complementary therapies in fibromyalgia syndrome].
Interdisciplinary S3 level guidelines were devised in cooperation with 8 medical, 2 psychological and 2 patient support groups. Results were elaborated in a multilevel group process. ⋯ Within a multicomponent therapy setting, selective CAM therapies (acupuncture, vegetarian diet, homeopathy, Tai Chi, Qi Gong, music-oriented and body-oriented therapies) can be recommended for a limited period of time.
-
An interdisciplinary guideline for the treatment of fibromyalgia syndrome (FMS) and chronic widespread pain (CWP) was developed in cooperation with ten German medical and psychological associations and two patients' self-help organizations. ⋯ The recommendations regarding pharmacological treatment of FMS are limited by the short duration of the RCT, the lack of follow-ups and absence of cost-effectiveness studies.